NEVUS FLAMMEUS

Clinical trials for NEVUS FLAMMEUS explained in plain language.

Never miss a new study

Get alerted when new NEVUS FLAMMEUS trials appear

Sign up with your email to follow new studies for NEVUS FLAMMEUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New light therapy aims to fade Port-Wine birthmarks safely

Disease control Recruiting now

This study tests a light-activated drug called hemoporfin to treat port-wine birthmarks (red or purple skin marks). About 84 adults aged 18 to 75 will receive either the drug or a placebo, followed by different amounts of light. The goal is to find the safest and most effective l…

Matched conditions: NEVUS FLAMMEUS

Phase: PHASE2 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated May 04, 2026 16:23 UTC

NEVUS FLAMMEUS

Get alerted when new NEVUS FLAMMEUS trials appear

New light therapy aims to fade Port-Wine birthmarks safely